Newcorn, Jeffrey H.

Response Inhibition in Adolescents Diagnosed With Attention Deficit Hyperactivity Disorder During Childhood: An Event-Related fMRI Study

Schulz, K. P., Fan, J., Tang, C. Y., Newcorn, J. H., Buchsbaum, M. S., Cheung, A. M., & Halperin, J. M. (2004) · American Journal of Psychiatry

Attention Deficit Hyperactivity DisorderNeural and Behavioral Psychology Studies

Cited by 262

Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects

MOLINA, B. S. G., FLORY, K., HINSHAW, S. P., GREINER, A. R., ARNOLD, L. E., SWANSON, J. M., HECHTMAN, L., JENSEN, P. S., VITIELLO, B., HOZA, B., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 255

Neuropsychological outcome in adolescents/young adults with childhood ADHD: Profiles of persisters, remitters and controls.

Halperin, J. M., Trampush, J. W., Miller, C. J., Marks, D. J., & Newcorn, J. H. (2008) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 252

Brain dopamine transporter levels in treatment and drug naive adults with ADHD

Volkow, N. D., Wang, G.-J., Newcorn, J., Fowler, J. S., Telang, F., Solanto, M. V., Logan, J., Wong, C., Ma, Y., Swanson, J. M., et al. (2007) · NeuroImage

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 249

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

Volkow, N. D., Wang, G.-J., Tomasi, D., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F. W., Fowler, J. S., Logan, J., Wong, C. T., et al. (2012) · The Journal of Neuroscience

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 237

Systematic review: nonmedical use of prescription stimulants: risk factors, outcomes, and risk reduction strategies

Faraone, S. V., Rostain, A. L., Montano, C. B., Mason, O., Antshel, K. M., & Newcorn, J. H. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry

Neuroethics, Human Enhancement, Biomedical InnovationsSubstance Abuse Treatment and Outcomes

Cited by 225

Neurocognitive Functioning in AD/HD, Predominantly Inattentive and Combined Subtypes

Solanto, M. V., Gilbert, S. N., Raj, A., Zhu, J., Pope-Boyd, S., Stepak, B., Vail, L., & Newcorn, J. H. (2007) · Journal of Abnormal Child Psychology

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 195

Atomoxetine Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder

Newcorn, J. H., Spencer, T. J., Biederman, J., Milton, D. R., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 174

Methylphenidate Dosage for Children With ADHD Over Time Under Controlled Conditions: Lessons From the MTA

VITIELLO, B., SEVERE, J. B., GREENHILL, L. L., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., ELLIOTT, G. R., HECHTMAN, L., JENSEN, P. S., HINSHAW, S. P., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 163

Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder

Wilens, T. E., McBurnett, K., Bukstein, O., McGough, J., Greenhill, L., Lerner, M., Stein, M. A., Conners, C. K., Duby, J., Newcorn, J., et al. (2006) · Archives of Pediatrics & Adolescent Medicine

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 160

Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD

Arnold, L. E., Elliott, M., Sachs, L., Bird, H., Kraemer, H. C., Wells, K. C., Abikoff, H. B., Comarda, A., Conners, C. K., Elliott, G. R., et al. (2003) · Journal of Consulting and Clinical Psychology

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 159

Annual Research Review: Perspectives on progress in ADHD science – from characterization to cause

Sonuga‐Barke, E. J. S., Becker, S. P., Bölte, S., Castellanos, F. X., Franke, B., Newcorn, J. H., Nigg, J. T., Rohde, L. A., & Simonoff, E. (2023) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research

Cited by 157

Atomoxetine Alone or Combined With Fluoxetine for Treating ADHD With Comorbid Depressive or Anxiety Symptoms

Kratochvil, C. J., Newcorn, J. H., Arnold, L. E., Duesenberg, D., Emslie, G. J., Quintana, H., Sarkis, E. H., Wagner, K. D., Gao, H., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 152

Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder

Wang, G.-J., Volkow, N. D., Wigal, T., Kollins, S. H., Newcorn, J. H., Telang, F., Logan, J., Jayne, M., Wong, C. T., Han, H., et al. (2013) · PLoS ONE

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 144

Assessing medication effects in the MTA study using neuropsychological outcomes

Epstein, J. N., Keith Conners, C., Hervey, A. S., Tonev, S. T., Eugene Arnold, L., Abikoff, H. B., Elliott, G., Greenhill, L. L., Hechtman, L., Hoagwood, K., et al. (2006) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 139

The Link Between Health-Related Quality of Life and Clinical Symptoms Among Children with Attention-Deficit Hyperactivity Disorder

MATZA, L. S., RENTZ, A. M., SECNIK, K., SWENSEN, A. R., REVICKI, D. A., MICHELSON, D., SPENCER, T., NEWCORN, J. H., & KRATOCHVIL, C. J. (2004) · Journal of Developmental & Behavioral Pediatrics

Attention Deficit Hyperactivity DisorderHealth Systems, Economic Evaluations, Quality of Life

Cited by 119

Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder

Schulz, K. P., Fan, J., Bédard, A.-C. V., Clerkin, S. M., Ivanov, I., Tang, C. Y., Halperin, J. M., & Newcorn, J. H. (2012) · Archives of General Psychiatry

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 114

Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment

Pappadopulos, E., Jensen, P. S., Chait, A. R., Arnold, L. E., Swanson, J. M., Greenhill, L. L., Hechtman, L., Chuang, S., Wells, K. C., Pelham, W., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderMedication Adherence and Compliance

Cited by 112

Stimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder Moderates Adolescent Academic Outcome

Powers, R. L., Marks, D. J., Miller, C. J., Newcorn, J. H., & Halperin, J. M. (2008) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 104

Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder

Wilens, T. E., Newcorn, J. H., Kratochvil, C. J., Gao, H., Thomason, C. K., Rogers, A. K., Feldman, P. D., & Levine, L. R. (2006) · The Journal of Pediatrics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 102

Fading Memories: Retrospective Recall Inaccuracies in ADHD

Miller, C. J., Newcorn, J. H., & Halperin, J. M. (2010) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 101

Clinical Responses to Atomoxetine in Attention-Deficit/Hyperactivity Disorder: The Integrated Data Exploratory Analysis (IDEA) Study

Newcorn, J. H., Sutton, V. K., Weiss, M. D., & Sumner, C. R. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 92

Discriminant Validity of Attention-Deficit Hyperactivity Disorder

HALPERIN, J. M., NEWCORN, J. H., MATIER, K., SHARMA, V., McKAY, K. E., & SCHWARTZ, S. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 81

Effects of Atomoxetine on Growth in Children with Attention-Deficit/Hyperactivity Disorder Following up to Five Years of Treatment

Spencer, T. J., Kratochvil, C. J., Sangal, R. B., Saylor, K. E., Bailey, C. E., Dunn, D. W., Geller, D. A., Casat, C. D., Lipetz, R. S., Jain, R., et al. (2007) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 75